Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
about
Maitotoxin converts the plasmalemmal Ca(2+) pump into a Ca(2+)-permeable nonselective cation channel.Maitotoxin-4, a Novel MTX Analog Produced by Gambierdiscus excentricus.N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors.Glucose and lactate regulate maitotoxin-activated Ca2+ entry in spermatogenic cells: the role of intracellular [Ca2+].Calmodulin modulates the delay period between release of calcium from internal stores and activation of calcium influx via endogenous TRP1 channels.
P2860
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@ast
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@en
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@nl
type
label
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@ast
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@en
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@nl
prefLabel
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@ast
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@en
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@nl
P2093
P2860
P1476
Characterization of the maitotoxin-activated cationic current from human skin fibroblasts
@en
P2093
Juan Ramón Martínez-François
Verónica Morales-Tlalpan
P2860
P356
10.1113/JPHYSIOL.2001.013036
P407
P577
2002-01-01T00:00:00Z